Related Experiment Video
Updated: Jan 31, 2026

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets
Jihyun Kim1, June Hyuk Kim2, Hyun Guy Kang2,3
1Clinical Genomic Analysis Branch, Research Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang, Gyeonggi, 10408, South Korea.
Background:
Several studies have investigated the molecular drivers and therapeutic targets in adult soft tissue sarcomas. However, such studies are limited by the genomic heterogeneity and rarity of sarcomas, particularly in those with complex and unbalanced karyotypes. Additional biomarkers are needed across sarcoma types to improve therapeutic strategies. To investigate the molecular characteristics of complex karyotype sarcomas (CKSs) for therapeutic targets, we performed genomic profiling.
Results:
The mutational landscape showed that TP53, ATRX, and PTEN genes were highly mutated. CKS samples were categorized into three groups based on copy number variations that were associated with CDK4 and RB1 signatures. Integrated analysis of genomic and transcriptomic data revealed several pathways related to PDGFR, which could be a strategic target for anti-sarcoma therapy.
Conclusions:
This study provides a detailed molecular classification of CKSs and proposes several therapeutic targets. Targeted or combinational therapies for treating CKS should be considered before chemotherapy.
Insights
Genomic profiling of complex karyotype sarcomas (CKSs) identified key mutated genes and pathways. These findings suggest targeted therapies, such as those inhibiting PDGFR, may be more effective than chemotherapy for CKS treatment.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Adult soft tissue sarcomas exhibit genomic heterogeneity and rarity, complicating the identification of therapeutic targets.
- Studies on molecular drivers are limited, especially for sarcomas with complex karyotypes.
- There is a need for additional biomarkers to enhance therapeutic strategies across diverse sarcoma types.
Purpose of the Study:
- To investigate the molecular characteristics of complex karyotype sarcomas (CKSs).
- To identify potential therapeutic targets within CKSs through genomic profiling.
Main Methods:
- Genomic profiling was performed on CKS samples.
- Mutational landscape analysis was conducted.
- Copy number variations were assessed and samples categorized into distinct groups.
- Integrated analysis of genomic and transcriptomic data was performed.
Main Results:
- TP53, ATRX, and PTEN genes were found to be highly mutated in CKSs.
- Three distinct CKS groups emerged based on copy number variations, linked to CDK4 and RB1 signatures.
- Integrated analyses revealed PDGFR-related pathways as potential strategic targets for anti-sarcoma therapy.
Conclusions:
- The study provides a detailed molecular classification of CKSs.
- Several novel therapeutic targets have been identified for CKSs.
- Targeted or combinational therapies should be prioritized over chemotherapy for CKS treatment.
Related Concept Videos
Molecular and Ionic Solids
Molecular Solids
Molecular crystalline solids, such as ice, sucrose (table sugar), and iodine, are solids that are composed of neutral molecules as their constituent units. These molecules are held together by weak intermolecular forces such as London dispersion forces, dipole-dipole interactions, or hydrogen bonds, which...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Therapeutic Index
Integration by Parts: Indefinite Integrals
Molecular Models
Integration by Parts: Definite Integrals

